Abstract
5-Lipoxygenase catalyzes the committed step in the biosynthesis of the powerful
proinflammatory leukotrienes and pro-resolving anti-inflammatory lipoxins. Here we present
a 3.3 Å cryo-EM structure of wild type 5-lipoxygenase in complex with ATP, one of its most
important allosteric regulators. The nucleotide is located in a positively charged pocket of the
catalytic domain and held in place by a complex network of amino acid side chains and
backbone carbonyl and amino groups. Mutagenetic analysis suggests that ATP binding and
action is primarily mediated via Lys320, assisted by Gln657. Further atomistic simulations
demonstrate that ATP binding induces movements of the PLAT domain coupled to
conformational rearrangements at the active center. These findings provide important
structural and regulatory insights to a key enzyme in leukotriene biosynthesis, thus aiding in
design of new antiphlogistic drugs.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
3
Introduction
Leukotrienes are potent lipid mediators in inflammatory conditions such as asthma, rhinitis
and cardiovascular diseases, while lipoxins and related compounds have anti-inflammatory
and pro-resolving properties
1, 2 . 5-Lipoxygenase (5-LOX) is the central enzyme in the
leukotriene and lipoxin cascades where it oxidizes arachidonic acid into 5 S-hydro(pero)xy
eicosatetraenoic acid (5S-H(p)ETE), which is further dehydrated to yield the unstable epoxide
intermediate leukotriene A 4. Unlike other members of the lipoxygenase family, 5-LOX is
subject to complex regulation by phosphorylation, membrane association, and several soluble
allosteric factors, most notably calcium and ATP. In intact immune cells, 5-LOX traffics
from the cytosol or nucleosol to the perinuclear membrane, where it meets up with its partner
protein, FLAP, which is required for maximal activity and leukotriene output.
Due to inherent instability, 5-LOX escaped structural characterization for decades until
Newcomer and coworkers succeeded in crystallizing a variant of 5-LOX engineered to
improve stability and solubility. The structure of this mutated protein, named Stable 5-LOX,
was solved at 2.4 Å resolution
3.
ATP is one of the classical factors known to stimulate 5-LOX and is required to reach
maximal enzyme activity in vitro
4. The EC50 of ATP has been estimated to ~30 µM and both
the initial hydroperoxidation of arachidonic acid (AA) and the following epoxidation into
LTA
4, are stimulated by the nucleotide 5, 6 . The mechanism of 5-LOX activation by ATP is
not known but involves binding of the nucleotide to a presumed allosteric site in the protein
without any apparent hydrolysis of phosphodiester bonds. Here, we determined the cryo-EM
structure of wildtype 5-LOX at 3.3 Å resolution in complex with ATP. Together with
biochemical and computational evidence the structure reveals the molecular basis for ATP
regulation of 5-LOX and offers insights to the mechanism for this allosteric enzyme activator.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
4
Results
AND DISCUSSION
Cryo-EM structure of wild type 5-LOX in complex with ATP
Single-particle cryo-EM data were collected for wild-type 5-LOX prepared in the presence of
ATP, yielding a high-quality 3.3 Å resolution map (Table 1, Supplementary Table 1 and
Supplementary Fig. 1) with excellent map support for 90% of the model (Fig. 1A and 1B).
Overall, the wild-type 5-LOX structure is virtually identical to the crystal structure of Stable
5-LOX
3, exhibiting a C α RMSD-value of 0.675 Å. 5-LOX exhibits a typical lipoxygenase
structure with the N-terminal residues 1-116 folded into a C2-like, so called PLAT
(Polycystin-1, Lipoxygenase, Alpha-Toxin) domain, also referred to as the
β -barrel domain,
fused to a larger catalytic domain harboring the non-heme iron (Fig. 1C). Five major cavities
were found in wild-type 5-LOX (Supplementary Fig. 3), one of which (pocket 1, P1) likely
binds AA (Fig. 1E-F).
Table 1. Refinement and validation of Cryo-EM data
Map resolution (FSC 0.143, masked) 3.3 Å
Map sharpening B-factor (Ų) -110
Model–map CC (mask) 0.84
RMSD bonds (Å) / angles (°) 0.008 / 1.42
MolProbity score 1.78
Clashscore 6.2
Ramachandran favored / allowed / outliers (%) 96.8 / 3.2 / 0
Extended data collection, refinement and validation statistics are provided in Supplementary Table 1.
An arched helix with the invariant Leu415 at its vertex, shields access to the catalytic iron in
P1. The neighboring α 2 helix (α 2H) distinguishes itself from other LOX homologues. Rather
than an elongated helix with six to seven turns, as in 8-LOX and 15-LOX, it is a short three
turn helix flanked by extended loops in wildtype 5-LOX
7. Of note, these two helices are
included in three segments, comprising residues Ser172-Ser216, Al α 95-Thr302 and Glu418-
Gly430, which lack density, likely due to inherent flexibility, thereby preventing reliable
modeling. This interpretation agrees well with the fact that the arched helix and
α 2H were
recently suggested to regulate access to the catalytic site via conformational switching
between open and closed states
7. We obtained further support for this notion, as neural
network-based classification revealed a class comprising 10 k particles, yielding a low-
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
5
resolution map with support for α 2H in a closed conformation (Supplementary Fig. 2).
However, this feature was not maintained when refined to higher resolution.
Figure 1. Cryo-EM structure of wild-type 5-LOX in complex with ATP. A The density
map of 5-LOX is presented in blue. B The model of 5-LOX is colored in green, white and red
for map-model correlation values of 0.7, 0.6, and 0.5, respectively. Thus, α 2H as well as parts
of the arched helix lack map support. C The model of 5-LOX resolved at 3.3 Å showing the
catalytic domain (purple) and C2-like PLAT domain (yellow). The bound A TP molecule is
depicted in stick representation with carbon atoms in yellow, phosphorus in orange, nitrogen
in blue and oxygen in red. D The 5-LOX protein surface is colored using a red (negative),
white (neutral) and blue (positive) color gradient for Coulombic electrostatic potential (ESP)
in the range of -5 to +5 kcal/(mol·e), respectively. The bound ATP molecule is depicted in
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
6
stick representation with carbon atoms in yellow, phosphorus in orange, nitrogen in blue and
oxygen in red. E, F Solvent-accessible pockets in the catalytic domain (P1–P3) were
identified in the 5-LOX structure using PyVOL with volume thresholds of 1.5–4.0 ų. P1
corresponds to the catalytic site (yellow), while P3 represents the ATP-binding pocket (grey).
The
α 2H and arched helix covering the catalytic site (P1) are highlighted in pink and light
purple, respectively. The pocket P2 (green) is of unknown function. See related
Supplementary Fig. 3, containing additional pockets and docking simulations with the AA
substrate.
The catalytic Fe
2+ is liganded by the terminal carboxylate of Ile674, the amide-oxygen of
Asn555 as well as the imidazole groups of residues His368, His373 and His551. The terminal
Ile674 is supported by weaker density, compared to the other ligands, extending to cover the
entire residue and parts of the preceding Ala673. This suggests increased conformational
flexibility at the terminal region of wild type 5-LOX as further explored by MD simulations.
Architecture of the ATP binding site
In the complex structure, unmodeled density in the vicinity of residues Lys320, Lys656 and
Gln657 indicated the position of ATP. The negatively charged phosphates of ATP are held in
place by two positively charged residues Lys320 and Lys656. Notably, Lys656 is preceded by
Lys655 and Lys654, also recognized as the “ KKK” motif of 5-LOX (Fig. 2A, 2B and
Supplementary Table 2). The
α -phosphate group forms hydrogen bonds with the backbone
amide groups of Gln657 and Leu658 (Fig. 2C). Additionally, Lys320 interacts with the γ -
phosphate while Gln657 engages the β -phosphate group of ATP. The adenine of ATP is held
in place via aromatic interactions with residue Tyr235 and a hydrogen bond between its
amino group and the backbone carbonyl oxygens of Leu231 and Ile321 (Fig. 2C). Its ribose is
coordinated via its hydroxyl groups by the side-chain amino groups of Lys320 and Lys656
(Fig. 2C). On either side of the A TP molecule, Tyr468 and Tyr235 form
π –π interactions in an
edge-to-plane geometry, characteristic of many nucleotide-binding proteins, likely guiding
the adenine into its correct position. In addition, the aromatic ring of Tyr468 forms a donor-
π
association with the side chain of Lys320, possibly stabilizing the positioning of Lys320,
ribose and
γ -phosphate group (Fig. 2C). Along with Tyr235 and Tyr468, other aromatic
residues such as Phe470, Tyr471, Tyr660 and Tyr662 appear to participate in aromatic
stacking or
π –π interactions near the A TP binding pocket and may contribute to structural
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
7
rearrangements of α -helices and the C-terminal loop upon A TP binding. The binding site of
ATP in the cryo-EM structure was also accurately predicted by AlphaFold38.
Figure 2. Binding of ATP to 5-LOX. A The ATP molecule bound to its cavity. B Map and
model are shown for ATP and surrounding residues. Atoms of the model are colored as
follows: carbon as white or yellow, oxygen as red, nitrogen as blue, sulfur as yellow and
phosphorus as orange. C Summary of residues or backbone peptide bonds interacting with
ATP. Residues involved via backbone amide or carbonyl groups are indicated in italics.
Distances of polar, hydrophobic and aromatic interactions are presented with polar (cyan),
hydrophobic (purple) and aromatic (orange) dashed lines.
MD simulations show flexible but stable ATP binding consistent with cryo-EM
MD simulations of the wild-type structure bound to ATP (ATP+), performed in triplicate
(total 1,5 µs), showed stable and consistent modes of ATP binding. Across all three
simulations, the ATP phosphate groups were predominantly stabilized by Lys320 and
Lys656. The amino group of the adenine ring maintained stable hydrogen bond interactions
with Ile321 and Leu231 throughout the trajectories, with Leu231 also intermittently
contacting the imidazole moiety. Meanwhile, the backbone of Gln657 engaged intermittently
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
8
with the ribose hydroxyl groups and/or phosphates, whereas its side chain only formed
transient contacts in all replicates. The ribose ring was periodically contacted by Lys320,
Lys656, Gln657, and Leu658. Finally, Tyr468 established cation– π contacts with the Lys320
or Lys656 side chains in all simulations. These simulations pointed to Lys320, Lys656, and
Gln657 as potentially most important in anchoring ATP’s phosphate and ribose moieties,
echoing the binding poses observed in the cryo-EM structure.
ATP spontaneous binding in MD simulations
To evaluate how ATP could spontaneously bind to 5-LOX and to explore potential allosteric
effects, we initiated a set of simulations (ATP+out) where ATP was positioned 10 Å from the
predicted pocket with its phosphate moiety faced away from the 5-LOX binding site. Overall,
these simulations indicate that ATP remains near the binding site for most of each trajectory,
primarily through interactions between its phosphate groups and basic residues (Lys320,
Lys654, Lys655, and Lys656) located at the pocket entrance. These interactions may
facilitate the initial capture of ATP via long-range electrostatic forces. In replicates 1 and 2,
ATP stays stably engaged, with replicate 1 even showing spontaneous partial penetration
toward the inner cavity—although not to the depth observed in the cryo-EM structure, which
would likely require more extensive sampling
Lys320 is critical for ATP induced allosteric activation of 5-LOX
Selected amino acids with side chains interacting with ATP in the cryo-EM structure were
mutated to probe their role in ATP stimulated 5-LOX activity. Exchange of a charged Lys for
a hydrophobic Leu at position 320 (Lys320Leu) abolished basal activity (in presence of Ca
2+
and phosphatidyl choline) and rendered the enzyme insensitive to ATP (Fig. 3A). This
appears reasonable in view of this residue’s multiple electrostatic and polar interactions with
the nucleotide, observed in the cryo-EM structure (Fig. 2).
In contrast, the Lys656Leu mutant had increased 5-LOX activity in both absence and
presence of ATP, suggesting that this residue is not critical for ATP induced 5-LOX
activation but rather for basal enzyme activity. Interestingly, a similar increase in overall 5-
LOX activity, albeit to a lesser extent, was previously reported by Horn et al. when mutating
Lys656 into the polar Gln
9 and in fact many other lipoxygenases carry a Leu in this position
suggesting that the charged Lys656 may instead play an attenuating role specifically for 5-
LOX enzyme activity. This notion is also in line with a previous study suggesting that the
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
9
three adjacent Lys 654-656, termed the “KKK motif”, in 5-LOX plays a suppressive role for
enzyme activity10.
When the neighboring Gln657 was exchanged for a Leu, the mutant lost all its basal enzyme
activity but responded significantly to ATP, albeit to approx. half of the response exhibited
by wild type 5-LOX. Hence, Gln657 does indeed contribute to ATP binding and 5-LOX
activation. Removal of the aromatic ring at position 468, yielded the Tyr468Ala mutant
whose activity and ATP sensitivity were not significantly different from wild type enzyme.
Finally, in the double mutant Lys320Leu/Lys656Leu the Lys320/Leu mutation dominated the
phenotype with only slightly improved basal and ATP stimulated activity when combined
with the activating Lys656/Leu alteration. Taken together these observations support a crucial
role for Lys320 in ATP binding and allosteric activation of 5-LOX. While Gln657 also
contributes to the effects of ATP, the role of Lys656 seems to be more important for basal 5-
LOX activity than ATP stimulation. Finally, interactions of Tyr468 with ATP do not seem to
contribute to allosteric activation of the enzyme.
Figure 3. ATP-dependent activation and binding capabilities of wild-type 5-LOX and
mutants. A Activity assays were performed in the presence of AA (75 µM), Ca
2+ (0.8 mM),
phosphatidylcholine (20 µg/mL), 13S-HpODE (7.5 µM), with (+) or without (-) ATP (3.75
mM) at room temperature for 10 min. Statistical comparisons were made between wild-type
5-LOX (+ATP) and each mutant. All differences are statistically significant (p
/i5 </i5 0.05),
except for 5-LOX Y468A, which is indicated as not significant (n.s.). Data are presented as
mean ± SEM, based on at least four independent experiments (N). B ATP-binding capacity of
wild-type 5-LOX (WT) and mutants were assessed by ATP affinity chromatography. Proteins
retained on the ATP column were detected by immunoblotting. The ratios of ATP to AMP
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
10
fractions (ATP/AMP) were determined, reflecting the ATP binding efficiency. See related
Supplementary Figures 4 and 5 for panels A and B, respectively.
A qualitative ATP binding assay was performed using ATP-Sepharose affinity columns to
assess the relative binding of wild-type 5-LOX and its mutants. Fractions from each
purification step were analyzed via Western Blot (Supplementary Fig. 5). The comparison of
fractions eluted with ATP or AMP (ATP/AMP) represents the pool of proteins that bind
strongly to the column and, after multiple washing steps (including AMP elution), can only
be eluted with ATP (Fig. 3B). The relative binding scores (ATP/AMP) demonstrate high
ATP affinity for wild-type 5-LOX and the Gln657Leu and Tyr468Ala variants, all of which
retained sensitivity to ATP. In contrast, for the Lys320Leu, Lys656Leu and
Lys320Leu/Lys656Leu mutants, AMP quite efficiently competed with ATP binding and
these mutants showed decreased ATP sensitivity. The seemingly weak binding of Lys656Leu
mutant to the ATP-Sepharose suggests that its enhanced enzyme activity is driven by
conformational changes rather than ATP binding.
ATP binding decouples PLAT domain versus catalytic domain motions in 5-LOX
To dissect how ATP modulates 5-LOX dynamics, we performed molecular dynamics
simulations of the wild-type enzyme in the absence of ATP (ATP–), with ATP bound
(ATP+), or positioned near the binding pocket (ATP+out), totaling nearly 7
μ s of sampling
with two different force-fields to model iron coordination (see Methods, Supplementary Figs.
6-9). While the first simulation used CHARMM36m with the Won force-field11 defaults, well
suited to capture large-scale protein motions 12, the second introduced tighter iron binding
parameters, developed by Li-Merz13, allowing the comparison of the trade-off between local
and global dynamics when modelling ATP binding effects. Our first simulation set revealed
rigidity for stable 5-LOX, both global and at the level of the iron coordination site, which
remained within canonical distances with virtually absent breathing (see Supplementary
Table 3). In contrast, simulations of the wild-type structure (ATP-) revealed increased
breathing of the catalytic center, especially upon ATP binding (Supplementary Figs. 10-11,
Supplementary Tables 4-5), coupled to increased global flexibility (Supplementary Fig. 12,
Supplementary Table 6). In our cryo-EM structure, and in trajectories of wild type enzyme
without ATP (ATP-), the PLAT and catalytic domains form a compact interface stabilized by
salt bridges linking Arg102 in the PLAT domain to Asp167 and Glu623 in the catalytic
domain, together with an Asp80–Arg166 contact. These interactions maintain the enzyme in
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
11
a closed conformation. However, in ATP+ and ATP+out simulations this contact network is
progressively disrupted, allowing up to ~43° rotation of the PLAT domain about the hinge
linker (residues 114–125) and increasing the interdomain separation by ~30 Å (Fig. 4A).
Root Mean Square Fluctuation (RMSF) profiles and domain center-of-mass distributions
confirm this enhanced flexibility under ATP-bound conditions (Fig. 4A, B & Supplementary
Fig. 7, 9). Dynamic cross-correlation analysis (DCCM; ATP– minus ATP+) reveals a loss of
coordinated motion (Fig. 5C right, red) between the catalytic hinge (residues 114–115) and
the flexible C-terminal helix (residues 624–627), consistent with release of interdomain
restraints and facilitating large-scale pivoting of the PLAT domain (Fig. 4C; Supplementary
Figs. 12-14). These domain-scale changes recapitulate Small-Angle X-ray Scattering (SAXS)
observations for the homologous 15-LOX-1 enzyme
14. Furthermore, residues within the ATP
binding pocket show reduced correlation with the PLAT domain in the ATP-bound state (Fig.
5C right, red), while ATP binding induces new or enhanced correlated motions with the
catalytic core (Fig. 5C right, blue), reflecting a dynamic rewiring of communication pathways
across the enzyme. While simulations performed with the Won Fe
2+ parameters captured
these experimentally reported large-amplitude motions reproducibly, those employing the Li–
Merz Fe
2+ model which enforces a tighter metal coordination with virtually no breathing
(Supplementary Fig. 11, Supplementary Table 4) showed only modest oscillations
(“trembling”) around the closed state and weaker ATP-dependent transitions (Supplementary
Figs. 10 & 11). In this case, ATP only induced a broader span of motion and increased
maximal values in some metrics capturing PLAT-catalytic domain distances (See e.g.
distance between residues 102-403, Supplementary Fig. 12 & Supplementary Table 6). This
difference indicates that the Li–Merz potential enforces a tighter coupling between the
catalytic iron and its coordinating ligands, maintaining Fe
2+-ligand distances near expected
values (Supplementary Table 7) and thereby limiting long-range allosteric motions.
Importantly, Fe
2+ remained bound in both the Won (Supplementary Fig. 10) and Li-Merz
(Supplementary Fig. 11) models, but in the former, breathing of the catalytic pocket clearly
depended on the wild-type sequence and ATP- induction. Of note, quantum chemical
calculations of representative structures captured in MD simulations of ATP-, ATP+ and
ATP+out, using the Won model, revealed that all Fe
2+-ligand interactions were overall
attractive (negative total energies), indicating that even the most relaxed configurations
observed in MD remain energetically stable (Supplementary Fig. 15; Supplementary Table
8).
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
12
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
13
Figure 4. ATP binding allosterically decouples PLAT versus catalytic domain motions
in MD simulations of wild type 5-LOX, favoring opening. A Distribution of center-of-
mass distances between the PLAT and catalytic domains in Won simulations. Representative
closed and open states from ATP- and ATP+ trajectories are shown. B Root Mean Square
Fluctuations (RMSF) across MD simulations of wild type 5-LOX in absence of ATP (ATP-),
and with ATP bound (ATP+) or partly bound near its binding site (ATP+out) (3x500 ns each,
1.5
μ s per condition). Increased flexibility in the PLAT domain is seen as higher peaks (blue)
in RMSF. C Right: Dynamic Cross-Correlation Matrix (DCCM) difference map comparing
the ATP– and ATP+ states. The heatmap represents correlation differences calculated as
DCCM(ATP–) minus DCCM(ATP+). Red regions indicate residue pairs that are more
positively correlated in the ATP– state and decoupled in the ATP+ state, while blue regions
highlight correlations strengthened in the ATP+ state. White regions represent minimal
change between conditions. A representative structural mapping of regions with the strongest
correlation differences is shown on the left.
ATP induced remodeling of cavities and gate loops
In both simulation sets, however, ATP binding also remodels the internal cavity network
surrounding the catalytic iron. In Won simulations, concomitant with enhanced fluctuations
at the metal center, the catalytic pocket (Pocket 1) in wild type 5-LOX (Fig. 5A, yellow)
undergoes pronounced expansion in both volume and solvent-accessible surface area,
particularly when ATP adopts the anchored conformation (ATP+out) (Fig. 5B,
Supplementary Fig. 16). On the opposite side of the metal center, the second largest pocket
detected, Pocket 2 in Fig. 5A (green), is delimited by two flexible, gate-like surface loops
(residues 610–615 and 170–176) whose motions are dynamically coupled to the PLAT
domain (Fig. 4C & Supplementary Figs. 13-14). These loops open more widely in ATP-
bound trajectories, increasing solvent access to the catalytic site. In the ATP– state, they are
stabilized in a closed configuration by transient salt bridges (notably Glu613–Lys174) and
secondary contacts involving Glu623 and Arg102 from the PLAT domain. Although the
PLAT domain does not directly occlude Pocket 2, its closed orientation reinforces this gate
through its structural linkage, while ATP binding promotes its relaxation. In addition, the
catalytic pocket extends from the Fe
2+ center toward the surface through two channels capped
by Trp148 and Trp600. While Trp148 remains closed, Trp600 alternates between closed and
open states and remains predominantly open in ATP-bound trajectories (Fig. 5D), forming a
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
14
potential “gated” route for substrate entry. Remarkably, in the dynamically restrained Li-
Merz simulations, a subtler increase in volume for the catalytic pocket is also seen upon ATP
binding (Supplementary Fig. 16). Together, these observations support a model in which
ATP acts allosterically to prime 5-LOX for catalysis by coupling nucleotide binding to
relaxation of the Fe
2+ coordination sphere, local cavity breathing and increased PLAT-
domain oscillations - motions that may not only facilitate catalysis, but also membrane
engagement.
Figure 5. ATP binding induces an increase in the volume of the main catalytic pocket
and opening of Trp600 . A Spatial relationship of the two major pockets detected in MD
simulations (snapshot at 120 ns from ATP-). The catalytic pocket (Pocket 1, yellow mesh)
extends from the Fe
2+ center toward the protein surface and is gated by Trp148 and Trp600 at
two alternative exits. Pocket 2 (green mesh), is located on the opposite side of the catalytic
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
15
iron (orange), enclosed at one end by the metal center and at the other by two flexible gate-
like loops (green, residues 610–615 and 170–176). For reference, α 2H is highlighted in pink
with the so-called FY -cork represented as sticks (Phe178, Tyr182), while the arched helix is
colored in blue. B Changes in volume and solvent accessibility are especially significant for
Pocket 1 upon ATP interactions (see also Supplementary Figure 16). C The gate-like loops
covering Pocket 2 exhibit increased opening in the presence of ATP (light blue) and are
stabilized in a closed conformation by transient salt bridges in A TP-free simulations (green).
Representative snapshots were captured at 465 ns. D Trp600 in closed (pink) or open (green)
gating in representative snapshots at 190 ns from simulations in absence and presence of ATP.
Trp148 (pink) maintains a stable conformation across all simulations. The catalytic pocket
(yellow) expands in presence of ATP.
Conclusions
The cryo-EM structure of wild-type 5-LOX reveals how ATP engages a positively charged
pocket within the catalytic domain to modulate enzyme activity. Functional assays identify
Lys320, supported by Gln657, as the key mediator of ATP-dependent activation. Atomistic
simulations corroborate these findings and demonstrate how ATP can induce long-range,
dynamic conformational changes of the PLAT domain and catalytic center to prime 5-LOX
for catalysis and readiness for membrane association. Taken together, our findings offer novel
insights to the structural and mechanistic basis of ATP-mediated allosteric regulation in 5-
LOX and provide new perspectives for selective modulation of leukotriene biosynthesis.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
16
Materials and methods
Materials
The list of materials is presented in Supplementary Table 9.
Cloning and site-directed mutagenesis
The expression construct containing the codon-optimized Twin-strep-tagged wild-type 5-
LOX (TS-wt5-LOX) sequence in the pET21a(+) vector was synthesized by GenScript. The
mutations in the wild-type sequence were carried out using Phusion Site-Directed
Mutagenesis Kit (Thermo Scientific™). The mutagenesis primers were synthesized by
Integrated DNA Technologies. The introduced mutations were validated by sequencing.
Plasmids encoding TS-wt5-LOX or mutated TS-5-LOX, which were transformed into
Escherichia coli BL21(DE3) competent cells.
Protein preparation
E. coli BL21(DE3) cells were grown at 37 °C in in 8 L Terrific Broth medium supplemented
with 100 µg/mL ampicillin to an OD600 of 0.5. The protein expression was induced with 0.5
mM IPTG and cells were incubated overnight at 15 °C. Cells were harvested by
centrifugation at 5,000 x g for 10 min and suspended in 50 mL of lysis buffer containing 50
mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 tablet of cOmplete™ EDTA-free protease inhibitor
cocktail, 1 mg/mL hen egg lysozyme, 250 U of Benzonase® Nuclease. Cells were disrupted
by sonication with Sonics Vibra Cell sonicator equipped with the standard tip at 40%
amplitude for 1 h (5 s on and 10 s off) and cell debris was removed by centrifugation at
12,000 × g for 1 h at 4 °C. The supernatant was loaded on an immobilized Strep-Tactin®
Superflow® column (3 mL; IBA Lifesciences) equilibrated with 100 mM Tris–HCl pH 8,
150 mM NaCl, 1 mM EDTA. The proteins were eluted with 100 mM Tris-HCl pH 8.0, 150
mM NaCl, 1 mM EDTA, 2.5 mM desthiobiotin. The protein was loaded on an 1 mL ATP-
agarose column equilibrated with 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 10 mM 2-
mercaptoethanol. The column was washed with the same buffer containing 12 mM AMP and
eluted with the buffer supplemented with 12 mM ATP. Freshly eluted 0.5 mL fractions were
quantified using the Bradford assay and were used immediately for the cryo-EM grid
preparation.
Activity assay
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
17
Small-scale expressions of wild-type and mutated 5-LOX were carried out in 10 mL Terrific
Broth-ampicillin medium at 15 °C overnight. Cells were harvested in 0.5 mL of 50 mM Tris
(pH 8.0) buffer, sonicated with the Sonics Vibra Cell sonicator equipped with a micro tip at
40% amplitude for 5 x 5 seconds and centrifuged at 15,000 x g for 10 min. Next, 50 µL and 3
µL of supernatant was used in incubation assays and Western Blot analysis, respectively. The
activity assay was carried in 200 µL of 50 mM Tris (pH 8.0) buffer containing 100 µM
arachidonic acid (AA), 150 mM NaCl, 1.2 mM EDTA, 2 mM CaCl
2, 10 µM 13S-HpODE
and 25 µg/mL phosphatidyl choline, in absence or presence of 3.75 mM ATP, for 10 min at
room temperature. The reaction was stopped with equal volume of MeOH containing 200
pmol of the 17S-HDoTE standard. 5-LOX products, 5S-H(p)ETE and LTA
4, were quantified
using reverse-phase HPLC. Samples were analyzed on a 3.9 × 150-mm column (C18; Nova-
Pak Waters) by eluting products at a flow rate of 1 mL/min with acetonitrile/ water/acetic
acid at a ratio of 60:40:0.1 (vol/vol). Absorbance was monitored at 235 nm and the 5-LOX
activity was determined in picograms per 1 min in 1 mL, calculated from integrated HPLC
peak areas relative to internal standards. The activity of 5-LOX mutants are presented relative
to the activity of wild-type 5-LOX and normalized with the protein expression levels
determined with Western Blot. Results are presented using the GraphPad Prism program.
Protein binding assay
Wild-type 5-LOX and mutants were expressed and purified from 200 mL cultures as
described in the Protein Preparation section. Aliquots were collected from supernatant,
flowthrough, wash and elution steps with 12 mM AMP and 12 mM ATP to assess their
binding capacity to the ATP column.
Western Blot
Proteins were transferred to nitrocellulose membranes using the iBlot2 instrument. The
membranes were blocked with 3% milk solution for 1 hour at room temperature. The
membranes were treated with in-house 5-LOX primary antibody
15 at 4 oC overnight followed
by incubation with anti-rabbit HRP-conjugated secondary antibody for 1 hour at room
temperature. The membranes were developed using SuperSignal™ West Pico PLUS
Chemiluminescent Substrate (Thermo Scientific) on the Li-Cor Odyssey instrument.
Cryo-EM data collection
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
18
The grids were glow-discharged for 120 s at 35 mA, then prepared in the following manner:
3.5 µL of sample at 50 µg/ml were applied two times on UltrAuFoil 1.2/1.3 300 mesh Au
grids and plunge-frozen in liquid nitrogen-cooled liquid ethane using a Vitrobot Mark IV
(Thermo Fisher Scientific) with a blot force of 3 and 5 s blot time, at 4 °C and 100%
humidity. Grids were clipped and loaded into a 300 kV Titan Krios G3 electron microscope
with cold field emission gun (Thermo Fisher Scientific, EPU software). Grids were screened
for quality based on particle distribution and density, and images from the best grid were
recorded. Data were acquired using a Gatan K3 direct electron detector with Bioquantum
energy filter (10 eV) in counting mode at a nominal magnification of 165 000 x,
corresponding to a pixel size of 0.5076 Å. A total of 8600 movies were recorded with an
accumulated electron dose of ~65 e−/Ų. Details of the other data collection parameters used
for each sample are given in Supplementary Table 1.
Cryo-EM SPA processing and model building
8205 movies were pre-processed applying batch motion- and CTF-correction jobs in
cryoSPARC
16. 993 micrographs were discarded interactively by thresholding the CTF fit
resolution to below 10 Å, the average defocus to below 20,285 Å and the relative ice
thickness to between 0.7 and 1.3. Blob picking with minimal and maximal diameters of 80
and 200
/i5 Å, respectively, followed by particle inspection yielded 1,607,961 particles. These
particles were extracted with a box size of 400 binned to 128 pixels, corresponding to a pixel
size of 1.586 Å. 357,451 particles were selected in 37 out of 200 2D classes (Supplementary
Fig. 2A), aligned in three final full and 50 online EM iterations with a batch size of 200, a
maximum resolution of 8 Å and a circular mask of 120 Å. Four volumes comprising 24 079,
40 493, 15 172 and 20 256 particles were reconstructed ab initio from a subset comprising
100 k particles from the selected 2D classes. Iterative heterogeneous refinements with four
volumes were applied to isolate a stack of 130,978 particles that was refined homogeneously
to a resolution of 3.3 Å. After re-extracting the particles with a box size of 400 binned to 192
pixels (1.0575 Å pixel size), non-uniform refinement 2 improved the resolution of the
reconstruction to 3.05 Å. However, the map exhibited streaky features and conical FSC
(cFSC) summary plots revealed a wide directional resolution range between 6.79 and
2.75
/i5 Å. Furthermore, the cFSC Area Ratio (cFAR) value of 0.08 indicated strong orientation
bias (Supplementary Fig. 2B and 2C). After importing the particle stack into Relion with the
help of the UCSF pyem suite
17, 18 , 3D auto-refinement with Blush regularization (Relion-
blush)19 led to a significantly improved reconstruction (Supplementary Fig. 2B and 2C). The
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
19
obtained map appeared more isotropic, the cFSC resolution range became narrower (3.92 →
2.72 Å) and the cFAR metric increased to 0.31. The particle stack was downsampled to
64/i5 pixels (3.1725 Å pixel size) and analyzed in CryoDRGN 20, 21 by training the neural
network with an 8-dimensional latent variable model for 50 epochs on the default 1024x3
architecture. Iterative conformational landscape analysis with ward linkage for agglomerative
clustering resulted in three classes comprising 97,636, 23,181 and 9,618 particles. 3D auto-
refinement using Relion-blush of each class revealed a significantly worse reconstruction for
the 97 k class (Supplementary Fig. 2C) compared to the other two classes. While the initial
low resolution map of the 10 k particle stack indicated map support for the a2H in a closed
conformation (Supplementary Fig. 1C), this feature was not maintained when refined to
higher resolution. The two classes comprising 23 k and 10 k particles were combined for the
final Relion-blush 3D auto-refinement (Supplementary Fig. 2B). The narrower cFSC
resolution range (3.61
→ 2.95 Å) and increased cFAR metric (0.56) of the high quality
reconstruction indicated further map improvement. The refined wild-type 5-LOX structure
exhibits Molprobity evaluation score and model-to-map cross-correlation (cc) values of 1.24
and 0.8, respectively, demonstrating a physically valid model with excellent map support for
90% of the model. The primary and secondary maps deposited under EMDB code 52771
were post-processed applying Phenix’s model-based local anisotropic sharpening
22 with an
effective average B-sharpening value of -53 Å 2 and EMready 23 with the deposited mask,
respectively. The recommended viewing threshold levels of the primary, secondary and half-
maps are at values of 5, 0.01 and 0.01, respectively. The AlphaFold-predicted
24, 25 structure of
5-LOX [https://alphafold.ebi.ac.uk/entry/P09917] was docked into the map using Phenix 26.
The catalytic iron was transferred from the superimposed crystal structure of the stable 5-
LOX mutant [https://www.rcsb.org/structure/3o8y
]3. The position of the ATP ligand was
predicted accurately by AlphaFold38 to occupy an unmodeled density located in the vicinity
of residues K320 and Q657. The model was refined and validated iteratively using Coot,
Isolde, Phenix’s real space refinement and Molprobity
27, 28, 29, 30 . The structure was analyzed
and visualized using PyMOL 31, ChimeraX, Arpeggio, VMD and custom-made scripts in
Python and Rstudio32, 33, 34, 35, 36, 37.
Cavity mapping and molecular docking
Binding pockets and cavity volumes in 5-LOX were calculated using the PyVOL tool
(v1.7.6) within the PyMOL molecular visualization program. Pocket detection was performed
with a minimum radius of 1.5 Å (1.2 Å for narrower cavities), a maximum probe radius of 5
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
20
Å, and a minimum pocket volume threshold of 200 ų. Interaction sites between the catalytic
pocket of 5-LOX and AA or 5S-HpETE were predicted via molecular docking using the cryo-
EM structure of 5-LOX as a template. Ligands were prepared in Avogadro (v1.2.0). Prior to
the docking, all non-essential molecules, except the catalytic non-heme iron, were removed
from the cryo-EM structure. Simulations were carried out with AutoDock Vina (v1.2) through
the UCSF Chimera (v1.19) interface, with the exhaustiveness parameter set to 8. Binding
modes with the best docking scores (kcal/mol) were visualized using PyMOL (v3.1.5.1).
Molecular dynamics simulations and analysis
MD simulations were performed using the cryo-EM structure of wild-type human 5-LOX in
three distinct conditions: (1) ATP–, in which ATP was removed and the structure relaxed; (2)
ATP+, with ATP bound in the nucleotide pocket; (3) ATP+ out, where ATP was displaced 10
Å from the pocket with its phosphate moiety facing away to prevent immediate interactions.
This design enabled exploration of both bound and capture-like ATP states. Each system was
prepared independently using CHARMM-GUI, which imported the experimental coordinates,
built the simulation box, added solvent and ions, and applied periodic boundary conditions.
Protein parameters were described by the CHARMM36m force field
38, while ATP
parameters were taken from the CHARMM36 all-hydrogen nucleic-acid topology. The Fe 2+
cofactor was represented using the CHARMM ion parameters developed by Won (Won et al.
2012)11, which accurately captured the stability of the Fe binding site in preliminary
simulations of stable 5-LOX (see below), and re-run again with tighter Fe2+ parameters by Li-
Merz (Li et al. 2013)13 obtaining similar results. Each system was solvated in a rectangular
TIP3P water box 39 extending 10 Å from the solute, and neutralized with K + and Cl - ions at
0.15 M using Monte Carlo ion placement. All titratable residues were assigned standard
protonation states at pH 7.0 according to CHARMM-GUI defaults, including appropriate
histidine tautomers. All simulations were carried out with GROMACS 2024.3
40 using
periodic boundary conditions. Each system underwent energy minimization by steepest
descent (converged at Fmax
≤ 1000 kJ mol -1 nm-1), followed by equilibration in the NVT
ensemble (constant number of particles, volume, and temperature) for 125 ps with a 1 fs
timestep. Production simulations were then performed in the NPT ensemble (constant number
of particles, pressure and temperature) at 303.15 K with three independent replicas per
system, each initiated with randomized Maxwell–Boltzmann velocities. Stable 5-LOX was
simulated for 600 ns in two replicas, while for the ATP–, ATP+, and ATP+out systems, each
replicate was run for 500 ns (2 fs timestep; 2.5 x 10
8 steps). The velocity-rescale thermostat
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
21
and Parrinello–Rahman barostat were used for temperature and pressure coupling,
respectively. Long-range electrostatics were treated with particle-mesh Ewald, and covalent
bonds to hydrogen were constrained using LINCS.
Trajectory post-processing was performed with GROMACS utilities. Each trajectory was
centered on the protein, periodicity was removed, and frames were extracted every 1 ns. For
subsequent analyses, three replica trajectories were concatenated per condition to perform
principal component analysis (PCA) and define global motions in a unified structural space.
Analyses included RMSD, RMSF, domain distance measurements, iron-coordination
dynamics, and dynamic cross-correlation matrices (DCCM) to quantify allosteric coupling.
All analyses were conducted using MDAnalysis (v2.7.0)
41, 42 with Pandas 43 and NumPy 44,
and Matplotlib and Seaborn 45 for statistical treatment and visualization. Cavities were
identified with MDpocket from the Fpocket suite46, and molecular graphics were generated in
PyMOL31.
Acknowledgments: We are grateful to Dr. Martin Hällberg and the Karolinska Institutet 3D-
EM facility: https://ki.se/cmb/3d-em
and computational resources from the Swedish National
Infrastructure for Computing (NAISS 2023/5-400, NAISS 2024/5-88, NAISS 2024/1-7 and
NAISS 2024/3-5)
Funding: This work was supported by the Swedish Research Council (2023-02312; 2024-
06825; 2021-02248), Novo Nordisk Foundation (NNF0064142) The Swedish Cancer Society
(CF 21 0305 JIA, CF 1471 Pj, CF 24 3801 Pj) and Karolinska Institutet. We acknowledge
support from the SciLifeLab & Wallenberg Data Driven Life Science Program, Knut and
Alice Wallenberg Foundation (grants: KAW 2020.0239 and KAW 2017.0003), and by the
National Bioinformatics Infrastructure Sweden (NBIS) at SciLifeLab.
Author contributions: T.T. produced 5-LOX, carried out mutational analysis, and collected
cryo-EM data. MD simulations were carried out and analysed by F.P. and L.O.. A.N.H.
carried out quantum chemical calculations O.R. helped analyze data, gave intellectual input
and revised the MS. T.T. did initial data processing and T.S. solved the cryo-EM structure.
T.T, F.P., L.O., T.S. and J.Z.H wrote the manuscript J.Z.H conceptualized, planned and
supervised the project.
Competing interests: The authors declare no competing interests.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
22
Reference
LIST
1. Haeggström JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry,
biology, and roles in disease. Chem Rev 111, 5866–5898 (2011).
2. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510,
92–101 (2014).
3. Gilbert NC , et al. The structure of human 5-lipoxygenase. Science 331, 217–219 (2011).
4. Rådmark O, Werz O, Steinhilber D, Samuelsson B. 5-Lipoxygenase, a key enzyme for
leukotriene biosynthesis in health and disease. Biochim Biophys Acta 1851, 331–339
(2015).
5. Aharony D, Stein RL. Kinetic mechanism of guinea pig neutrophil 5-lipoxygenase. J Biol
Chem 261, 11512–11519 (1986).
6. Smyrniotis CJ, Barbour SR, Xia Z, Hixon MS, Holman TR. ATP allosterically activates
the human 5-lipoxygenase molecular mechanism of arachidonic acid and 5(S)-
hydroperoxy-6(E),8(Z),11(Z),14(Z)-eicosatetraenoic acid. Biochemistry 53, 4407–4419
(2014).
7. Gallegos EM , et al. Helical remodeling augments 5-lipoxygenase activity in the synthesis
of proinflammatory mediators. J Biol Chem 298, 102282 (2022).
8. Abramson J, et al. Accurate structure prediction of biomolecular interactions with
AlphaFold 3. Nature 630, 493–500 (2024).
9. Horn T, Reddy Kakularam K, Anton M, Richter C, Reddanna P, Kuhn H. Functional
characterization of genetic enzyme variations in human lipoxygenases. Redox Biol 1, 566–
577 (2013).
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
23
10. Schexnaydre EE, Gerstmeier J, Garscha U, Jordan PM, Werz O, Newcomer ME. A
5/i5 lipoxygenase-specific sequence motif impedes enzyme activity and confers dependence
on a partner protein. Biochim Biophys Acta Mol Cell Biol Lipids 1864, 543–551 (2019).
11. Won Y. Force field for monovalent, divalent, and trivalent cations developed under
the solvent boundary potential. J Phys Chem A 116, 11763–11767 (2012).
12. Scaramozzino D, Lee BH, Orellana L. Breaking the size limit: efficient sampling of
large-scale transition pathways and intermediate conformations in sub-mesoscopic protein
complexes. ResearchSquare (2025).
13. Li P, Roberts BP, Chakravorty DK, Merz KM, Jr. Rational Design of Particle Mesh
Ewald Compatible Lennard-Jones Parameters for +2 Metal Cations in Explicit Solvent. J
Chem Theory Comput 9, 2733–2748 (2013).
14. Hammel M, Walther M, Prassl R, Kühn H. Structural flexibility of the N-terminal
beta-barrel domain of 15-lipoxygenase-1 probed by small angle X-ray scattering.
Functional consequences for activity regulation and membrane binding. J Mol Biol 343,
917–929 (2004).
15. Esser J , et al. Coactosin-like protein functions as a stabilizing chaperone for 5-
lipoxygenase: role of tryptophan 102. Biochem J 425, 265–274 (2009).
16. Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid
unsupervised cryo-EM structure determination. Nat Methods 14, 290–296 (2017).
17. Asarnow D, Palovcak E, Cheng Y. asarnow/pyem: UCSF pyem v0.5. Zenodo (2019).
18. Scheres SH. RELION: implementation of a Bayesian approach to cryo-EM structure
determination. J Struct Biol 180, 519–530 (2012).
19. Kimanius D , et al. Data-driven regularization lowers the size barrier of cryo-EM
structure determination. Nat Methods 21, 1216–1221 (2024).
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
24
20. Zhong ED, Bepler T, Berger B, Davis JH. CryoDRGN: reconstruction of
heterogeneous cryo-EM structures using neural networks. Nat Methods 18, 176–185
(2021).
21. Kinman LF, Powell BM, Zhong ED, Berger B, Davis JH. Uncovering structural
ensembles from single-particle cryo-EM data using cryoDRGN. Nat Protoc 18, 319–339
(2023).
22. Terwilliger TC, Sobolev OV, Afonine PV, Adams PD. Automated map sharpening by
maximization of detail and connectivity. Acta Crystallogr D Struct Biol 74, 545–559
(2018).
23. He J, Li T, Huang SY. Improvement of cryo-EM maps by simultaneous local and
non-local deep learning. Nat Commun 14, 3217 (2023).
24. Varadi M , et al. AlphaFold Protein Structure Database: massively expanding the
structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids
Res 50, D439–D444 (2022).
25. Jumper J , et al. Highly accurate protein structure prediction with AlphaFold. Nature
596, 583–589 (2021).
26. Liebschner D , et al. Macromolecular structure determination using X-rays, neutrons
and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol 75, 861–877
(2019).
27. Croll TI. ISOLDE: a physically realistic environment for model building into low-
resolution electron-density maps. Acta Crystallogr D Struct Biol 74, 519–530 (2018).
28. Davis IW , et al. MolProbity: all-atom contacts and structure validation for proteins
and nucleic acids. Nucleic Acids Res 35, W375–383 (2007).
29. Afonine PV , et al. Real-space refinement in PHENIX for cryo-EM and
crystallography. Acta Crystallogr D Struct Biol 74, 531–544 (2018).
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
25
30. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta
Crystallogr D Biol Crystallogr 60, 2126–2132 (2004).
31. Schrödinger L. The PyMOL Molecular Graphics System. 2.0 edn (2015).
32. Abraham MJ, et al. GROMACS: High performance molecular simulations through
multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015).
33. Pettersen EF , et al. UCSF ChimeraX: Structure visualization for researchers,
educators, and developers. Protein Sci 30, 70–82 (2021).
34. Jubb HC, Higueruelo AP, Ochoa-Montano B, Pitt WR, Ascher DB, Blundell TL.
Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in
Protein Structures. J Mol Biol 429, 365–371 (2017).
35. Wickham H , et al. Welcome to the Tidyverse. J Open Source Softw 4, (2019).
36. Wickham HG, Garrett. R for Data Science. O'Reilly Media (2017).
37. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph
14, 33–38, 27–38 (1996).
38. Huang J , et al. CHARMM36m: an improved force field for folded and intrinsically
disordered proteins. Nat Methods 14, 71–73 (2017).
39. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of
Simple Potential Functions for Simulating Liquid Water. J Chem Phys 79 , 926–935
(1983).
40. Abraham M , et al. GROMACS 2024.6 Manual. Zenodo (2025).
41. Gowers R , et al. MDAnalysis: A Python Package for the Rapid Analysis of Molecular
Dynamics Simulations. In: Proceedings of the 15th Python in Science Conference (2016).
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
26
42. Michaud-Agrawal N, Denning EJ, Woolf TB, Beckstein O. MDAnalysis: a toolkit for
the analysis of molecular dynamics simulations. J Comput Chem 32, 2319–2327 (2011).
43. Reback J , et al. pandas-dev/pandas: Pandas. Zenodo (2020).
44. Harris CR , et al. Array programming with NumPy. Nature 585, 357–362 (2020).
45. Hunter JD. Matplotlib: A 2D graphics environment. Comput Sci Eng 9, 90–95 (2007).
46. Schmidtke P, Bidon-Chanal A, Luque FJ, Barril X. MDpocket: open-source cavity
detection and characterization on molecular dynamics trajectories. Bioinformatics 27,
3276–3285 (2011).
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted November 26, 2025. ; https://doi.org/10.1101/2025.11.26.690380doi: bioRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.